If you have got sore, swollen joints, you have a better chance of overcoming arthritis because you are looking for the cause of your symptoms. But to find the right treatment you need to get a lot more specific than that. According to the Centers for Disease Control and Prevention …
Read More »
The FDA has rejected the submission of Gilead for approval of filgotinib in rheumatoid arthritis. With the FDA requesting to see data from an ongoing clinical trial, Gilead is unlikely to be able to refill until after the middle of next year, pushing it even further behind its rivals for …
Read More »
In the early days of the COVID-19 pandemic, Sanofi and Regeneron launched an ambitious plan to test rheumatoid arthritis with Kevzara in desperately ill patients. But after the first warning signs, a phase 3 failure has forced drug makers to make their judgment in the United States. Sanofi and Regeneron …
Read More »